Twist Bioscience (TWST) Other Non-Current Liabilities (2018 - 2026)
Twist Bioscience (TWST) reported Other Non-Current Liabilities of $746000.0 for Q1 2026, up 65.41% year-over-year from $451000.0 in Q1 2025, and up 0.67% quarter-over-quarter from $741000.0 in Q4 2025.
Twist Bioscience (TWST) Other Non-Current Liabilities (2018 - 2026) Analysis & Trends
Twist Bioscience (TWST) has 9 years of Other Non-Current Liabilities data on file, last reported at $746000.0 in Q1 2026.
- Other Non-Current Liabilities for Q1 2026 came in at $746000.0, up 65.41% year-over-year; the trailing twelve-month figure through Mar 2026 was $746000.0 (up 65.41% YoY), and the FY2025 annual result was $747000.0, up 83.54% from the prior year.
- Other Non-Current Liabilities rose to $746000.0 in Q1 2026 per TWST's latest filing, from $741000.0 in the prior quarter.
- Over five years, Other Non-Current Liabilities peaked at $8.1 million in Q1 2022 and troughed at $60000.0 in Q3 2022.
- A 5-year average of $976352.9 and a median of $475000.0 in 2023 frame the typical range for Other Non-Current Liabilities.
- On a YoY basis, Other Non-Current Liabilities climbed as much as 1830.57% in 2022 and fell as far as 99.79% in 2022.
- A 5-year view of Other Non-Current Liabilities shows it stood at $60000.0 in 2022, then jumped by 691.67% to $475000.0 in 2023, then retreated by 14.32% to $407000.0 in 2024, then surged by 82.06% to $741000.0 in 2025, then grew by 0.67% to $746000.0 in 2026.
- Business Quant data shows TWST's Other Non-Current Liabilities at $746000.0 in Q1 2026, $741000.0 in Q4 2025, and $747000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn |
| 10 | Twist Bioscience | 4.30 Bn | 4.30 Bn | 57.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 746,000.00 |
| Dec 31, 2025 | 741,000.00 |
| Sep 30, 2025 | 747,000.00 |
| Jun 30, 2025 | 688,000.00 |
| Mar 31, 2025 | 451,000.00 |
| Dec 31, 2024 | 407,000.00 |
| Sep 30, 2024 | 407,000.00 |
| Jun 30, 2024 | 597,000.00 |
| Mar 31, 2024 | 421,000.00 |
| Dec 31, 2023 | 475,000.00 |
| Sep 30, 2023 | 475,000.00 |
| Jun 30, 2023 | 60,000.00 |
| Mar 31, 2023 | 60,000.00 |
| Dec 31, 2022 | 60,000.00 |
| Sep 30, 2022 | 60,000.00 |
| Jun 30, 2022 | 2.06 Mn |
| Mar 31, 2022 | 8.15 Mn |
| Dec 31, 2021 | 28.37 Mn |
| Sep 30, 2021 | 5.07 Mn |
| Jun 30, 2021 | 12.28 Mn |